Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
Charlene M. Dawidczyk, Luisa M. Russell, Peter C. Searson
Frontiers in Chemistry (2014) Vol. 2
Open Access | Times Cited: 151

Showing 26-50 of 151 citing articles:

Nanoparticles for Advanced Photodynamic Therapy of Cancer
Heidi Abrahamse, Cherie Ann Kruger, Sania Kadanyo, et al.
Photomedicine and Laser Surgery (2017) Vol. 35, Iss. 11, pp. 581-588
Closed Access | Times Cited: 96
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Hyaluronic acid-conjugated lipid nanocarriers in advancing cancer therapy: A review
Guifeng Zhang, Xin Jiang, Yitong Xia, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140146-140146
Closed Access | Times Cited: 1
Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications
Fujuan Chai, Linlin Sun, Xinyi He, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 1791-1802
Open Access | Times Cited: 87
Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes, et al.
Frontiers in Bioengineering and Biotechnology (2017) Vol. 5
Open Access | Times Cited: 74
Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action
Luisa M. Russell, Margot Hultz, Peter C. Searson
Journal of Controlled Release (2017) Vol. 269, pp. 171-176
Open Access | Times Cited: 64
Biomarkers-based Biosensing and Bioimaging with Graphene for Cancer Diagnosis
Hui Gu, Huiling Tang, Ping Xiong, et al.
Nanomaterials (2019) Vol. 9, Iss. 1, pp. 130-130
Open Access | Times Cited: 64
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations
Mahendra Rai, Shital Bonde, Alka Yadav, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1224-1224
Open Access | Times Cited: 54
Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
Souhaila H. El Moukhtari, Carlos Rodríguez‐Nogales, María J. Blanco‐Prieto
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 238-251
Open Access | Times Cited: 52
Nano-bio fusion: Advancing biomedical applications and biosensing with functional nanomaterials
Shikha Uniyal, Kuldeep Choudhary, Surbhi Sachdev, et al.
Optics & Laser Technology (2023) Vol. 168, pp. 109938-109938
Closed Access | Times Cited: 20
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Judith W.J. Bergs, Matthias G. Wacker, Stephanie Hehlgans, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2015) Vol. 1856, Iss. 1, pp. 130-143
Closed Access | Times Cited: 62
Nanotechnologies for the treatment of colon cancer: From old drugs to new hope
Larissa Kotelevets, Eric Chastre, Didier Desmaële, et al.
International Journal of Pharmaceutics (2016) Vol. 514, Iss. 1, pp. 24-40
Closed Access | Times Cited: 59
Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis
Nishant S. Kulkarni, Yadir Guererro, Nilesh Gupta, et al.
Journal of Drug Delivery Science and Technology (2018) Vol. 49, pp. 352-364
Closed Access | Times Cited: 59
Multiscale simulations reveal IRMOF-74-III as a potent drug carrier for gemcitabine delivery
Marianna Kotzabasaki, Ioannis Galdadas, Emmanuel Tylianakis, et al.
Journal of Materials Chemistry B (2017) Vol. 5, Iss. 18, pp. 3277-3282
Closed Access | Times Cited: 56
Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition
Xiaoling Gao, Lihua Guo, Jianqiang Li, et al.
Journal of Controlled Release (2018) Vol. 292, pp. 29-57
Closed Access | Times Cited: 55
Nanodrugs used in cancer therapy
Kateřina Kopečková, Tomáš Eckschlager, Jakub Širc, et al.
Biomedical Papers (2019) Vol. 163, Iss. 2, pp. 122-131
Open Access | Times Cited: 51
In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer
Natalia Oddone, Nicole Lecot, Marcelo Fernández, et al.
Journal of Nanobiotechnology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers
Raksha Ghanghoria, Prashant Kesharwani, Rakesh Kumar Tekade, et al.
Journal of Controlled Release (2016) Vol. 269, pp. 277-301
Closed Access | Times Cited: 49
Recent advances of nanomedicines for liver cancer therapy
Xiaoqin Chi, Kun Liu, Xiangjie Luo, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 17, pp. 3747-3771
Closed Access | Times Cited: 45
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4 + colorectal cancer models
María Virtudes Céspedes, Ugutz Unzueta, Patricia Álamo, et al.
Nanomedicine Nanotechnology Biology and Medicine (2016) Vol. 12, Iss. 7, pp. 1987-1996
Open Access | Times Cited: 39
Revolutionizing targeting precision: microfluidics-enabled smart microcapsules for tailored delivery and controlled release
Lingling Ren, Shuang Liu, Junjie Zhong, et al.
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1367-1393
Closed Access | Times Cited: 4
Nanocarrier drugs in the treatment of brain tumors
Tereza Černá, Marie Stiborová, Vojtěch Adam, et al.
Journal of Cancer Metastasis and Treatment (2016) Vol. 2, Iss. 10, pp. 407-407
Open Access | Times Cited: 38
Application of Nanomedicine to the CNS Diseases
Dario Carradori, Alice Gaudin, D. Brambilla, et al.
International review of neurobiology (2016), pp. 73-113
Closed Access | Times Cited: 36
Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency
Charlene M. Dawidczyk, Luisa M. Russell, Margot Hultz, et al.
Nanomedicine Nanotechnology Biology and Medicine (2017) Vol. 13, Iss. 5, pp. 1637-1644
Open Access | Times Cited: 35
Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells
Emiliana Perillo, Émilie Allard-Vannier, Annarita Falanga, et al.
International Journal of Pharmaceutics (2015) Vol. 488, Iss. 1-2, pp. 59-66
Closed Access | Times Cited: 34

Scroll to top